
Global & New Zealand Cancer Therapeutics Market to 2031
Description
The cancer therapeutics market in New Zealand is influenced by a rising number of cancer cases, a robust healthcare infrastructure, and an increasing demand for advanced treatment options. Cancer remains a leading cause of illness and death, with lung, breast, prostate, and colorectal cancers being the most prevalent. The incidence of cancer has steadily grown in recent years, driven by factors such as an aging population, lifestyle changes, and environmental influences. Greater awareness and advancements in diagnostic methods have also contributed to earlier detection, which may partially explain the increase in reported cases. Additionally, New Zealand’s growing involvement in clinical trials has attracted international pharmaceutical companies, facilitating the introduction of innovative cancer therapies. The country’s regulatory agency, Medsafe, supports the approval of both generic and novel oncology drugs, fostering a competitive market for pharmaceutical manufacturers. Key players like Roche, Bristol-Myers Squibb, and Merck are actively providing cutting-edge cancer treatments.
Market growth is further supported by the aging population, high smoking prevalence—particularly impacting lung cancer rates—and a heightened focus on precision medicine, which personalizes therapies based on genetic profiles. New Zealand’s commitment to enhancing cancer care accessibility is demonstrated through programs like the National Cancer Programme, aimed at delivering newer and more effective treatment options.
Market growth is further supported by the aging population, high smoking prevalence—particularly impacting lung cancer rates—and a heightened focus on precision medicine, which personalizes therapies based on genetic profiles. New Zealand’s commitment to enhancing cancer care accessibility is demonstrated through programs like the National Cancer Programme, aimed at delivering newer and more effective treatment options.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. New Zealand Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. New Zealand Cancer Therapeutics Market – Analysis
- 6.1 New Zealand Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 New Zealand Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. New Zealand Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 New Zealand Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. New Zealand Cancer Therapeutics Market Analysis – by Indications
- 8.1 New Zealand Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. New Zealand Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 New Zealand Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. New Zealand Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. New Zealand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. New Zealand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. New Zealand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. New Zealand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. New Zealand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. New Zealand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. New Zealand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. New Zealand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. New Zealand Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.